ATE525071T1 - Verbindngen zur hemmung der sap-bindung zur behandlung von osteoarthritis - Google Patents

Verbindngen zur hemmung der sap-bindung zur behandlung von osteoarthritis

Info

Publication number
ATE525071T1
ATE525071T1 AT04736527T AT04736527T ATE525071T1 AT E525071 T1 ATE525071 T1 AT E525071T1 AT 04736527 T AT04736527 T AT 04736527T AT 04736527 T AT04736527 T AT 04736527T AT E525071 T1 ATE525071 T1 AT E525071T1
Authority
AT
Austria
Prior art keywords
osteoarthritis
treatment
compounds
sap binding
inhibiting
Prior art date
Application number
AT04736527T
Other languages
English (en)
Inventor
Mark Pepys
Philip Hawkins
Original Assignee
Pentraxin Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentraxin Therapeutics Ltd filed Critical Pentraxin Therapeutics Ltd
Application granted granted Critical
Publication of ATE525071T1 publication Critical patent/ATE525071T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
AT04736527T 2003-06-10 2004-06-10 Verbindngen zur hemmung der sap-bindung zur behandlung von osteoarthritis ATE525071T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0313386.5A GB0313386D0 (en) 2003-06-10 2003-06-10 Treatment of disease
PCT/GB2004/002445 WO2004108131A1 (en) 2003-06-10 2004-06-10 Compounds inhibiting the binding of sap for treating osteoarthritis

Publications (1)

Publication Number Publication Date
ATE525071T1 true ATE525071T1 (de) 2011-10-15

Family

ID=27589813

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04736527T ATE525071T1 (de) 2003-06-10 2004-06-10 Verbindngen zur hemmung der sap-bindung zur behandlung von osteoarthritis

Country Status (9)

Country Link
US (1) US7659299B2 (de)
EP (1) EP1633345B1 (de)
JP (1) JP2006527250A (de)
AT (1) ATE525071T1 (de)
AU (1) AU2004244815B2 (de)
CA (1) CA2528706C (de)
ES (1) ES2373553T3 (de)
GB (2) GB0313386D0 (de)
WO (1) WO2004108131A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1418905B1 (de) 2001-08-08 2007-05-02 Pentraxin Therapeutics Limited Wirkstoff zur entfernung einer unerwünschten proteinpopulation aus dem plasma
US20100297074A1 (en) * 2002-12-23 2010-11-25 Richard Hans Gomer Wound healing compositions, systems, and methods
EP2953970A4 (de) 2013-02-08 2016-06-29 Misfolding Diagnostics Inc Transthyretinantikörper und verwendungen davon
US9737505B2 (en) 2014-04-29 2017-08-22 Glaxosmithkline Intellectual Property Development Limited Prodrug of 1,1′-(1,6-dioxo-1,6-hexanediyl)bis-D-proline
GB201407506D0 (en) 2014-04-29 2014-06-11 Glaxosmithkline Ip Dev Ltd Novel compound

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62277352A (ja) * 1986-01-30 1987-12-02 Ono Pharmaceut Co Ltd 新規な６−ケト−プロスタグランジンｅ１誘導体、それらの製造方法およびそれらを有効成分として含有する細胞障害治療剤
US4895872A (en) * 1989-03-15 1990-01-23 Cetus Corporation Immunosupressive analogues and derivatives of succinylacetone
GB9317120D0 (en) 1993-08-17 1993-09-29 Royal Postgrad Med School Human serum amyloid p component
US6172045B1 (en) 1994-12-07 2001-01-09 Neorx Corporation Cluster clearing agents
PL336589A1 (en) 1997-05-02 2000-07-03 Akzo Nobel Nv Serinic protease inhibitors
US6365570B1 (en) * 1997-10-10 2002-04-02 Universiteit Utrecht Pharmaceutical and diagnostic use of Serum Amyloid P component
SI0915088T1 (en) * 1997-10-31 2002-12-31 F. Hoffmann-La Roche Ag D-proline derivatives
EP1418905B1 (de) * 2001-08-08 2007-05-02 Pentraxin Therapeutics Limited Wirkstoff zur entfernung einer unerwünschten proteinpopulation aus dem plasma
GB0119370D0 (en) * 2001-08-08 2001-10-03 Univ London Therapeutic agent
US6903129B2 (en) * 2001-12-14 2005-06-07 Hoffman-La Roche Inc. D-proline prodrugs
GB0211136D0 (en) * 2002-05-15 2002-06-26 Univ London Treatment and prevention of tissue damage
CA2525302A1 (en) * 2003-05-12 2004-11-18 David Bundle Multivalent inhibitors of serum amyloid p component

Also Published As

Publication number Publication date
GB0313386D0 (en) 2003-07-16
US20080249003A1 (en) 2008-10-09
EP1633345A1 (de) 2006-03-15
GB2420498A (en) 2006-05-31
EP1633345B1 (de) 2011-09-21
WO2004108131A1 (en) 2004-12-16
JP2006527250A (ja) 2006-11-30
CA2528706C (en) 2012-10-30
GB2420498B (en) 2007-11-28
CA2528706A1 (en) 2004-12-16
GB0600229D0 (en) 2006-02-15
AU2004244815B2 (en) 2009-12-10
AU2004244815A1 (en) 2004-12-16
ES2373553T3 (es) 2012-02-06
US7659299B2 (en) 2010-02-09

Similar Documents

Publication Publication Date Title
DE602004026891D1 (de) Tlr7-liganden zur behandlung von hepatitis c
ATE532518T1 (de) Dipeptidyl-peptidase-hemmer zur behandlung von diabetes
ATE453653T1 (de) Platinkomplexe zur behandlung von tumoren
DE122008000046I1 (de) Beta-amino-tetrahydroimidazo(1,2-a)pyrazine und -tetrahydrotriazolo(4,3-a)pyrazine als dipeptidyl peptidase inhibitoren zur behandlung oder prevention von diabetes
DE602004025708D1 (de) Ubiquitin-ligase-hemmer und verwandte verfahren
GEP20125511B (en) Mapk/erk kinase inhibitors
EA200970447A1 (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
DE502005001828D1 (de) Verwendung von rotigotin zur behandlung und prävention des parkinson-plus-syndroms
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
DE50310516D1 (de) Fredericamycin-derivate
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
TW200509949A (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
EP1556085A4 (de) Verbindungen zur behandlung von stoffwechselst rungen
ATE466841T1 (de) 1-phenethylpiperidinderivate und ihre verwendung als opioidrezeptor-liganden
DE60328603D1 (de) Prodrugs von imidazol-derivaten, zur verwendung als protonenpumpen-hemmer zur behandlung von z.b. peptischen magengeschwüren
TW200734334A (en) Treatment of substance abuse
DE602004011494D1 (de) Synergistische kombination enthaltend roflumilast und einen anticholinergischen wirkstoff ausgewählt aus tiotropiumsalzen für die behandlung von atemwegserkrankungen
WO2004073615A3 (en) Deazaflavin compounds and methods of use thereof
ATE525071T1 (de) Verbindngen zur hemmung der sap-bindung zur behandlung von osteoarthritis
TW200503666A (en) Treatment of type 1 diabetes with pde5 inhibitors
ATE406171T1 (de) Aplidine zur behandlung von multiplem myelom
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
DE602006002608D1 (de) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
ATE457727T1 (de) Kombination aus pyrimidylaminobenzamid- verbindungen und imatinib zur behandlung oder verhinderung proliferativer erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties